Table 5 Clinical outcomes following treatment
Patient | Follow-up MRI (days) | Post-op biopsy (outcome) | Most recent post-op PSA (months) | PSA (pre) (ng/ml) | PSA (post) (ng/ml) | Potent | Continent |
|---|---|---|---|---|---|---|---|
1 | 35 | +ve | 7 | 3.96 | 3 | Yes | Yes |
2 | 23 | +ve | 11 | 1.9 | 1.24 | Yes | Yes |
3 | 29 | +ve | 6 | 5.59 | 4.44 | Yes | Yes |
4 | 22 | −ve | 7 | 1.71 | 1.12 | Yes | Yes |
5 | 15 | −ve | 8 | 5.63 | 1.1 | Yes | Yes |
6 | 10 | −ve | 9 | 5.42 | 3.15 | Yes | Yes |
Mean (SD) | 22.3 (±9.07) | 8 (±1.78) | 4.03 (±1.83) | 2.17 (±1.59) |